siRNA-toting nanoparticles inhibit breast cancer metastasis Researchers combined finely crafted nanoparticles with one of nature's potent disrupters to prevent the spread of triple-negative breast cancer in mouse models. The researchers are working toward clinical trials.
New method developed to assess cancer risk of pollutants A faster, more accurate method to assess cancer risk from certain common environmental pollutants has been developed by scientists. The study focused on pollutants known as polycyclic aromatic hydrocarbons that commonly occur in the environment as diesel exhaust and cigarette smoke.
Potential new targets for cancer treatments identified Key steps in cell division have now been revealed by new research, possibly leading to treatments aimed at inhibiting cancer cell division.
First-in-class antibody mixture shows clinical activity against Tx-resistant, advanced CRC Sym004, a mixture of two anti-epidermal growth factor receptor antibodies, was found in patients with advanced colorectal cancer that had become resistant to prior therapies.
New treatment option for subtype of aggressive lymphoma A specific combination of mutations and new gene fusions have been discovered, that appear to be heavily implicated in tumor growth in patients with a particularly aggressive subtype of lymphoma. The findings could lead to new targeted treatments for this disease and even to successful treatment of other types of cancer